An appreciated Autumn Training 2023
The 9th-10th October 2023, MVIC arranged MVIC Autumn Training, which was one of our reoccurring two-day training courses in Inhalation Product Development. Find the Training dates for next year below.
MVIC Member Company Launches New Advanced Analytical Services
MVIC member company Emmace has a new collaboration agreement with Lund University. Read more below.
New Constellation of the MVIC Board
A new board of directors has been elected at MVIC. Read more below.
New Preclinical Inhalation Laboratory at the MVIC Member Company Truly Labs
MVIC offers preclinical inhalation studies through its member company Truly Labs. Now the preclinical inhalation activities at Truly Labs have moved to a better and more dedicated laboratory.
Evaluation of DSM as Carrier for Nasal Administration of APIs
In a recently started diploma project at MVIC member company, Magle Chemoswed, selected qualities of DSM and their suitability as carriers for nasal administration of pharmaceuticals are under evaluation.
MVIC at RDD Europe
Interested to meet? Please contact us, see below.
MVIC Strengthens Inhaler Testing Capacity
Within the MVIC network cluster, additional analytical capacity has been added in Emmace Consulting.
MVIC Back from DDL2022
After the great success of DDL2022, MVIC now looks forward to DDL2023.
Symposium 2024 – Delegate
Carrier-Based Formulations by Kyrre Thalberg
Part 2 of Kyrre Thalberg’s article series about carrier-based formulations has been published.